Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update.
Araújo FC, Sepriano A, Teixeira F, Jesus D, Rocha TM, Martins P, Tenazinha C, Cordeiro A, Mourão AF, Silva C, Vaz C, Duarte C, Ponte C, Dos Santos FP, Canhão H, Santos H, Pimentão JB, da Silva JC, Pereira J, da Silva JAP, Miranda LC, Oliveira M, Saavedra MJ, Gonçalves P, Falcão S, Capela S, Fonseca JE. Araújo FC, et al. Among authors: sepriano a. Acta Reumatol Port. 2017 Jul-Sep;42(3):219-228. Acta Reumatol Port. 2017. PMID: 28894080 English.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Sepriano A, Kerschbaumer A, Bergstra SA, Smolen JS, van der Heijde D, Caporali R, Edwards CJ, Verschueren P, de Souza S, Pope J, Takeuchi T, Hyrich K, Winthrop KL, Aletaha D, Stamm T, Schoones JW, Landewé RBM. Sepriano A, et al. Ann Rheum Dis. 2023 Jan;82(1):107-118. doi: 10.1136/ard-2022-223357. Epub 2022 Nov 14. Ann Rheum Dis. 2023. PMID: 36376026 Review.
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Kerschbaumer A, Sepriano A, Bergstra SA, Smolen JS, van der Heijde D, Caporali R, Edwards CJ, Verschueren P, de Souza S, Pope JE, Takeuchi T, Hyrich KL, Winthrop KL, Aletaha D, Stamm TA, Schoones JW, Landewé RBM. Kerschbaumer A, et al. Among authors: sepriano a. Ann Rheum Dis. 2023 Jan;82(1):95-106. doi: 10.1136/ard-2022-223365. Epub 2022 Nov 11. Ann Rheum Dis. 2023. PMID: 36368906
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Bergstra SA, Sepriano A, Kerschbaumer A, van der Heijde D, Caporali R, Edwards CJ, Verschueren P, de Souza S, Pope JE, Takeuchi T, Hyrich KL, Winthrop KL, Aletaha D, Stamm TA, Schoones JW, Smolen JS, Landewé RBM. Bergstra SA, et al. Among authors: sepriano a. Ann Rheum Dis. 2023 Jan;82(1):81-94. doi: 10.1136/ard-2022-223358. Epub 2022 Nov 21. Ann Rheum Dis. 2023. PMID: 36410794 Review.
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial.
Stal R, Ramiro S, van der Heijde D, van Gaalen FA, Baraliakos X, Machado PM, de Hooge M, van den Berg R, Reijnierse M, Braun J, Landewé R, Sepriano A. Stal R, et al. Among authors: sepriano a. RMD Open. 2023 Jul;9(3):e003118. doi: 10.1136/rmdopen-2023-003118. RMD Open. 2023. PMID: 37407237 Free PMC article. Clinical Trial.
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM.
Ramiro S, Landewé R, van der Heijde D, Sepriano A, FitzGerald O, Østergaard M, Homik J, Elkayam O, Thorne JC, Larché MJ, Ferraccioli G, Backhaus M, Boire G, Combe B, Schaeverbeke T, Saraux A, Dougados M, Rossini M, Govoni M, Sinigaglia L, Cantagrel AG, Allaart CF, Barnabe C, Bingham CO, van Schaardenburg D, Hammer HB, Dadashova R, Hutchings E, Paschke J, Maksymowych WP. Ramiro S, et al. Among authors: sepriano a. Rheumatology (Oxford). 2023 Sep 1;62(9):2989-2997. doi: 10.1093/rheumatology/kead021. Rheumatology (Oxford). 2023. PMID: 36645243
2011 Portuguese recommendations for the use of biological therapies in patients with psoriatic arthritis.
Machado P, Bogas M, Ribeiro A, Costa J, Neto A, Sepriano A, Raposo A, Cravo AR, Vilar A, Furtado C, Ambrósio C, Miguel C, Vaz C, Catita C, Nour D, Araújo D, Vieira-Sousa E, Teixeira F, Brandão F, Canhão H, Cordeiro I, Gonçalves I, Ferreira J, Fonseca JE, da Silva JA, Romeu J, Ferreira J, Costa L, Maurício L, Cunha-Miranda L, Parente M, Coutinho M, Cruz M, Oliveira M, Salvador MJ, Santos MJ, Pinto P, Valente P, Abreu P, Roque R, Ramiro S, Capela S, Las V, Barcelos A; Portuguese Society of Rheumatology. Machado P, et al. Among authors: sepriano a. Acta Reumatol Port. 2012 Jan-Mar;37(1):26-39. Acta Reumatol Port. 2012. PMID: 22781512 Free article.
The Portuguese Society of Rheumatology position paper on the use of biosimilars.
Fonseca JE, Gonçalves J, Araújo F, Cordeiro I, Teixeira F, Canhão H, da Silva JA, Garcês S, Miranda LC, Ramiro S, Roxo A, Pimentel-Santos FM, Tavares V, Neto A, Sepriano A, Malcata A, Faustino A, Silva C, Ambrósio C, Duarte C, Miguel C, Barcelos F, Santos H, Cunha I, Ramos JC, Gomes JA, Pimentão JB, Costa L, Maurício L, Silva M, Bernardes M, Bogas M, Coelho PC, Monteiro P, Aguiar R, André R, Leitão R, Pimenta S, Meirinhos T, Fernandes S, Las V, Castelão W; Sociedade Portuguesa de Reumatologia. Fonseca JE, et al. Among authors: sepriano a. Acta Reumatol Port. 2014 Jan-Mar;39(1):60-71. Acta Reumatol Port. 2014. PMID: 24811463 Review.
110 results